According to statistics, the number of children in China is 230 million, accounting for the total population of the country. In the future, it will be affected by the "two-child policy". The number of children will increase and the market for children's medicines has great potential. However, the domestic market for children's medicines has a large share. Occupied by a few foreign companies such as Wyeth, Roche, Bristol-Myers Squibb, etc. Developed countries have corresponding policy support in the development of children's special drugs, clinical trials, etc. , and provide tax, patent, market and research funding to pharmaceutical companies And other preferential measures. The text is intended to emphasize:. ['The domestic child medication medical market has great potential.', 'The domestic child medication medical market is basically monopolized by foreign companies.', "Developed countries support the development of children's medicines through various measures.", 'China needs to formulate corresponding policies to support the child medication medical market.']